These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 8102123)

  • 21. Ex vivo expansion of CD4 lymphocytes from human immunodeficiency virus type 1-infected persons in the presence of combination antiretroviral agents.
    Wilson CC; Wong JT; Girard DD; Merrill DP; Dynan M; An DD; Kalams SA; Johnson RP; Hirsch MS; D'Aquila RT
    J Infect Dis; 1995 Jul; 172(1):88-96. PubMed ID: 7541065
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factors Associated With the Control of Viral Replication and Virologic Breakthrough in a Recently Infected HIV-1 Controller.
    Walker-Sperling VE; Pohlmeyer CW; Veenhuis RT; May M; Luna KA; Kirkpatrick AR; Laeyendecker O; Cox AL; Carrington M; Bailey JR; Arduino RC; Blankson JN
    EBioMedicine; 2017 Feb; 16():141-149. PubMed ID: 28159573
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low blood CD8+ T-lymphocytes and high circulating monocytes are predictors of HIV-1-associated progressive encephalopathy in children.
    Sánchez-Ramón S; Bellón JM; Resino S; Cantó-Nogués C; Gurbindo D; Ramos JT; Muñoz-Fernández MA
    Pediatrics; 2003 Feb; 111(2):E168-75. PubMed ID: 12563091
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Asymptomatic CMV Replication During Early Human Immunodeficiency Virus (HIV) Infection Is Associated With Lower CD4/CD8 Ratio During HIV Treatment.
    Smith DM; Nakazawa M; Freeman ML; Anderson CM; Oliveira MF; Little SJ; Gianella S
    Clin Infect Dis; 2016 Dec; 63(11):1517-1524. PubMed ID: 27601222
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of the antiviral capacity of primary natural killer cells by optimized in vitro quantification of HIV-1 replication.
    He X; Simoneau CR; Granoff ME; Lunemann S; Dugast AS; Shao Y; Altfeld M; Körner C
    J Immunol Methods; 2016 Jul; 434():53-60. PubMed ID: 27094484
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dinitrochlorobenzene treatment of alopecia areata.
    de Prost Y; Paquez F; Touraine R
    Arch Dermatol; 1982 Aug; 118(8):542-5. PubMed ID: 7103522
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The distribution of immunocompetent cells in the genital tract of HIV-positive women.
    Olaitan A; Johnson MA; MacLean A; Poulter LW
    AIDS; 1996 Jun; 10(7):759-64. PubMed ID: 8805867
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term human immunodeficiency virus infection in asymptomatic homosexual and bisexual men with normal CD4+ lymphocyte counts: immunologic and virologic characteristics.
    Lifson AR; Buchbinder SP; Sheppard HW; Mawle AC; Wilber JC; Stanley M; Hart CE; Hessol NA; Holmberg SD
    J Infect Dis; 1991 May; 163(5):959-65. PubMed ID: 1673465
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunological abnormalities in the natural history of HIV infection: mechanisms and clinical relevance.
    Miedema F
    Immunodefic Rev; 1992; 3(3):173-93. PubMed ID: 1354968
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Innate Immune Activity Correlates with CD4 T Cell-Associated HIV-1 DNA Decline during Latency-Reversing Treatment with Panobinostat.
    Olesen R; Vigano S; Rasmussen TA; Søgaard OS; Ouyang Z; Buzon M; Bashirova A; Carrington M; Palmer S; Brinkmann CR; Yu XG; Østergaard L; Tolstrup M; Lichterfeld M
    J Virol; 2015 Oct; 89(20):10176-89. PubMed ID: 26223643
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of depression with viral load, CD8 T lymphocytes, and natural killer cells in women with HIV infection.
    Evans DL; Ten Have TR; Douglas SD; Gettes DR; Morrison M; Chiappini MS; Brinker-Spence P; Job C; Mercer DE; Wang YL; Cruess D; Dube B; Dalen EA; Brown T; Bauer R; Petitto JM
    Am J Psychiatry; 2002 Oct; 159(10):1752-9. PubMed ID: 12359683
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Suppression of HIV replication by lymphoid tissue CD8+ cells correlates with the clinical state of HIV-infected individuals.
    Blackbourn DJ; Mackewicz CE; Barker E; Hunt TK; Herndier B; Haase AT; Levy JA
    Proc Natl Acad Sci U S A; 1996 Nov; 93(23):13125-30. PubMed ID: 8917555
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Persistent immune activation in HIV-1 infection is associated with progression to AIDS.
    Hazenberg MD; Otto SA; van Benthem BH; Roos MT; Coutinho RA; Lange JM; Hamann D; Prins M; Miedema F
    AIDS; 2003 Sep; 17(13):1881-8. PubMed ID: 12960820
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phenotypic analysis of human immunodeficiency virus (HIV) type 1 cell-mediated immune responses after treatment with an HIV-1 immunogen.
    Moss RB; Wallace MR; Giermakowska WK; Webb E; Savary J; Chamberlin-Brandt C; Theofan G; Musil R; Richieri SP; Jensen FC; Carlo DJ
    J Infect Dis; 1999 Sep; 180(3):641-8. PubMed ID: 10438350
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemoimmunotherapy for melanoma with dacarbazine and 2,4-dinitrochlorobenzene elicits a specific T cell-dependent immune response.
    Wack C; Kirst A; Becker JC; Lutz WK; Bröcker EB; Fischer WH
    Cancer Immunol Immunother; 2002 Oct; 51(8):431-9. PubMed ID: 12202904
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sensitization to 2,4-dinitrochlorobenzene: influence of vehicle on absorption and lymph node activation.
    Heylings JR; Clowes HM; Cumberbatch M; Dearman RJ; Fielding I; Hilton J; Kimber I
    Toxicology; 1996 May; 109(1):57-65. PubMed ID: 8619253
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Actinic keratoses treated with a combination of topical 5-fluorouracil and dinitrochlorobenzene.
    Price NM
    Dermatologica; 1979; 158(4):279-86. PubMed ID: 428615
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship of virologic, immunologic, and clinical parameters in infants with vertically acquired human immunodeficiency virus type 1 infection.
    Muñoz-Fernández MA; Obregón E; Navarro J; Börner C; Gurbindo MD; Sampelayo TH; Fernández-Cruz E
    Pediatr Res; 1996 Oct; 40(4):597-602. PubMed ID: 8888289
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A pilot study to assess inflammatory biomarker changes when raltegravir is added to a virologically suppressive HAART regimen in HIV-1-infected patients with limited immunological responses.
    Lichtenstein KA; Armon C; Nagabhushanam V; Efaw BJ; Frazer-Abel A; Hiserote ME; Alam R
    Antivir Ther; 2012; 17(7):1301-9. PubMed ID: 22948290
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Downregulation of major histocompatibility class I on human dendritic cells by HIV Nef impairs antigen presentation to HIV-specific CD8+ T lymphocytes.
    Andrieu M; Chassin D; Desoutter JF; Bouchaert I; Baillet M; Hanau D; Guillet JG; Hosmalin A
    AIDS Res Hum Retroviruses; 2001 Sep; 17(14):1365-70. PubMed ID: 11602047
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.